El Sharkawy S L, Abbas N F, Badawi M A, El Shaer M A
Pathology Department, Medical Division, National Research Centre, Dokki Giza, Egypt.
J Clin Pathol. 2006 Nov;59(11):1171-4. doi: 10.1136/jcp.2005.033746. Epub 2006 Mar 30.
Metallothionein is a low-molecular-weight cysteine-rich protein that has the ability to bind and sequestrate heavy metal ions. It is associated with metalloregulatory functions such as cell proliferation, growth and differentiation.
To investigate the expression of metallothionein in hyperplastic, dysplastic and neoplastic prostatic lesions and to correlate its expression with histological grade of prostatic carcinoma.
The study was carried out on formalin-fixed and paraffin-wax-embedded tissue blocks from 8 patients with benign prostatic hyperplasia, 6 patients with prostatic intraepithelial neoplasia (PIN) and 30 patients with prostatic carcinoma, using the streptavidin-biotin technique. The histological grade was defined and the carcinomas were divided into low-grade (Gleason Score 2-4), 12 moderate grade (Gleason Score 5-6) and 10 high-grade (Gleason Score 7-10) carcinomas.
Patchy metallothionein staining of epithelial cells was observed in normal and benign prostatic tissues. All cases of PIN and 20 of 30 patients with prostatic carcinoma showed positive staining for metallothionein. Metallothionein expression considerably increased from low-grade to high-grade tumours. The proportion of cells staining positively for metallothionein was directly correlated with histological grade of prostatic carcinoma. The epithelial cells lack uniformity in staining intensity, but the percentage of strongly positive cells increased with the histological grade of prostatic carcinoma.
The high incidence of metallothionein expression in PIN in our study suggests that it is associated with early prostate tumorigenesis. Also, metallothionein expression was directly correlated with the histological grade of prostatic carcinoma, suggesting that metallothionein may be a useful marker for predicting the prognosis of prostate cancer.
金属硫蛋白是一种富含半胱氨酸的低分子量蛋白质,具有结合和螯合重金属离子的能力。它与细胞增殖、生长和分化等金属调节功能相关。
研究金属硫蛋白在前列腺增生、发育异常和肿瘤性病变中的表达,并将其表达与前列腺癌的组织学分级相关联。
使用链霉亲和素-生物素技术,对8例良性前列腺增生患者、6例前列腺上皮内瘤变(PIN)患者和30例前列腺癌患者的福尔马林固定石蜡包埋组织块进行研究。定义组织学分级,并将癌分为低级别(Gleason评分2-4)、12例中级(Gleason评分5-6)和10例高级别(Gleason评分7-10)癌。
在正常和良性前列腺组织中观察到上皮细胞的斑片状金属硫蛋白染色。所有PIN病例和30例前列腺癌患者中的20例显示金属硫蛋白染色阳性。从低级别到高级别肿瘤,金属硫蛋白表达显著增加。金属硫蛋白染色阳性的细胞比例与前列腺癌的组织学分级直接相关。上皮细胞染色强度缺乏一致性,但强阳性细胞的百分比随前列腺癌的组织学分级增加。
我们研究中PIN中金属硫蛋白表达的高发生率表明它与前列腺早期肿瘤发生相关。此外,金属硫蛋白表达与前列腺癌的组织学分级直接相关,表明金属硫蛋白可能是预测前列腺癌预后的有用标志物。